Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
60.24 USD 2.59 ( 4.49%)
Last update at 2026-11-03T21:21:00Z
VOLUME
66164
Market Cap
67.25M
P/E
35.13

Momentum Score

…

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
57.72
Low
62.59
High
52 Week Price Range
14.51
Low
22.99
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Pro-Dex, Inc. manufactures precision components and subassemblies for medical, dental and industrial equipment. Long-term growth drivers include outsourcing of medical and dental device manufacturing, aging-population healthcare demand, and wider adoption of minimally invasive technologies that may benefit precision suppliers. Investors may find the company attractive for its specialized manufacturing capabilities and exposure to healthcare end markets.
Material risks include customer concentration and cyclical capital spending in medical devices, competition from larger contract manufacturers, and execution or supply-chain issues that could pressure margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
57.65
Dividend Yield
-
Revenue TTM
49.46M
Revenue Per Share
13.99
Gross Profit TTM
12.75M
Debt / Equity
0.47
ROE
7.19%
Net Debt
11.86M
ROCE
14.37%
Diluted EPS TTM
0.56

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 9.43M 4.71M 5.63M 7.90M 5.45M
Net income 7.07M 3.85M 4.45M 6.11M 4.15M
Selling general administrative 4.03M 4.90M 4.08M 3.19M 2.49M
Selling and marketing expenses 0.15M 0.09M 0.59M 0.58M 0.41M
Gross profit 12.75M 13.13M 13.57M 13.14M 9.78M
Reconciled depreciation 0.86M 0.73M 0.69M 0.57M 0.44M
Ebit 6.06M 5.12M 4.53M 7.07M 5.00M
Ebitda 6.91M 5.96M 5.34M 8.68M 5.74M
Depreciation and amortization 0.86M 0.84M 0.81M 1.61M 0.74M
Non operating income net other - - 1.45M 1.07M 0.67M
Operating income 5.76M 5.12M 4.53M 7.07M 5.00M
Other operating expenses 40.33M 36.88M 33.50M 27.77M 22.18M
Interest expense 0.53M 0.46M 0.35M 0.24M 0.22M
Tax provision 2.35M 0.85M 1.18M 1.79M 1.30M
Interest income 0.29M 0.08M 0.13M 0.10M 0.27M
Net interest income -0.24M -0.39M -0.23M -0.14M 0.05M
Extraordinary items - - - - 0.01M
Non recurring - - - -0.01M -0.01M
Income tax expense 2.35M 0.85M 1.18M 1.79M 1.30M
Total revenue 46.09M 42.04M 38.03M 34.83M 27.17M
Total operating expenses 6.99M 7.97M 9.05M 6.08M 4.79M
Cost of revenue 33.34M 28.91M 24.45M 21.69M 17.39M
Total other income expense net 3.90M -0.42M 1.10M 0.84M 0.45M
Net income from continuing ops 7.07M 3.85M 4.45M 6.11M 4.15M
Net income applicable to common shares 7.07M 3.85M 4.45M 6.11M 4.15M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 51.82M 47.33M 40.32M 31.13M 25.52M
Intangible assets 0.08M 0.12M 0.19M 0.16M 0.13M
Other current assets 1.92M 1.50M 0.63M 0.30M 1.05M
Total liab 20.23M 23.66M 20.24M 12.06M 8.51M
Total stockholder equity 31.59M 23.67M 20.08M 19.06M 17.01M
Deferred long term liab - - - - 0.15M
Other current liab 2.72M 2.75M 2.20M 2.41M 1.44M
Common stock 6.77M 7.68M 7.95M 12.75M 15.81M
Capital stock 6.77M 7.68M 7.95M 12.75M 15.81M
Retained earnings 24.82M 15.99M 12.35M 7.90M 1.74M
Other liab 0.01M 0.54M 0.40M 0.80M 0.31M
Other assets 0.04M 0.84M 0.53M 0.30M 0.30M
Cash 2.94M 0.85M 3.72M 6.42M 7.74M
Total current liabilities 9.68M 10.81M 5.87M 5.23M 4.27M
Current deferred revenue 0.45M 1.01M 0.15M 0.20M 0.21M
Net debt 11.86M 14.74M 11.48M 0.26M -3.19M
Short term debt 4.24M 3.29M 1.24M 0.65M 0.62M
Short long term debt 3.83M 3.29M 1.24M 0.65M 0.62M
Short long term debt total 14.79M 15.59M 15.20M 6.68M 4.56M
Other stockholder equity - - -0.21M 0.41M 0.45M
Property plant equipment 13.20M 13.42M 3.85M 5.63M 2.73M
Total current assets 30.98M 31.17M 25.01M 22.67M 21.78M
Long term investments 7.52M 1.78M 1.70M 2.36M 0.58M
Net tangible assets 31.51M 23.55M 19.90M 18.90M 16.88M
Short term investments 1.13M 0.76M 1.29M 2.56M 2.65M
Net receivables 9.95M 15.38M 10.93M 5.16M 4.10M
Long term debt 8.91M 10.25M 11.54M 3.28M 3.93M
Inventory 16.17M 12.68M 8.44M 8.24M 6.24M
Accounts payable 2.26M 3.76M 2.29M 1.97M 2.00M
Accumulated other comprehensive income - - -0.21M -1.59M -0.55M
Common stock total equity - - 7.95M 12.75M 15.81M
Retained earnings total equity - - 12.35M 7.90M 1.74M
Non currrent assets other 0.03M 0.04M 0.07M 0.04M 0.04M
Deferred long term asset charges - - - - 0.26M
Non current assets total 20.84M 16.16M 15.31M 8.45M 3.74M
Capital lease obligations 2.05M 2.05M 2.43M 3.09M -
Long term debt total - - 11.54M 3.28M 3.93M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.89M 0.44M 4.60M -1.73M 0.17M
Change to liabilities -2.17M 2.85M -0.46M 0.63M 0.22M
Total cashflows from investing activities -0.89M -1.24M -3.71M -2.29M -1.22M
Net borrowings -0.81M 0.76M 8.79M -0.63M 4.51M
Total cash from financing activities -2.49M -0.79M 3.09M -3.98M 0.45M
Change to operating activities 0.71M -0.85M -0.35M 0.75M -0.72M
Net income 7.07M 3.85M 4.45M 6.11M 4.15M
Change in cash 2.09M -2.87M -2.70M -1.32M 2.55M
Begin period cash flow 0.85M 3.72M 6.42M 7.74M 5.19M
End period cash flow 2.94M 0.85M 3.72M 6.42M 7.74M
Total cash from operating activities 5.46M -0.85M -2.08M 5.90M 3.33M
Issuance of capital stock - - - - 0.00M
Depreciation 0.86M 0.73M 0.69M 0.57M 0.44M
Other cashflows from investing activities - - -0.04M -0.04M -0.00M
Dividends paid 0.09M - 0.26M 0.01M 0.02M
Change to inventory -3.49M -4.24M -0.20M -2.00M -1.85M
Change to account receivables 5.43M -4.45M -5.78M -1.06M -1.13M
Sale purchase of stock -1.55M -1.61M -5.54M -3.39M -3.98M
Other cashflows from financing activities -0.22M 2.00M 9.49M 0.04M 4.99M
Change to netincome -2.88M 1.10M -0.60M 0.24M 1.08M
Capital expenditures 0.97M 1.67M 8.31M 0.56M 1.40M
Change receivables - - -5.78M -1.06M -1.13M
Cash flows other operating - - -0.22M 0.44M 0.41M
Cash and cash equivalents changes - - -2.70M -1.32M 2.55M
Change in working capital 0.40M -6.54M -6.69M -1.08M -2.35M
Stock based compensation 0.77M 1.27M 0.90M 0.29M 0.04M
Other non cash items -3.90M 0.17M -1.25M 0.03M -0.37M
Free cash flow 4.49M -2.52M -10.38M 5.33M 1.93M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PDEX
Pro-Dex Inc
2.59
4.49%
60.24 35.13 13.07 1.31 1.99 1.45 12.50
ISRG
Intuitive Surgical Inc
3.88
0.89%
440.75 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
-2.00
0.95%
208.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
-1.89
1.80%
103.04 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
-0.66
0.33%
197.94 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Pro-Dex Inc

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

2361 McGaw Avenue, Irvine, CA, United States, 92614

949 769 3200

145

Name Title Year Born
Mr. Richard Lee Van Kirk Jr. CEO & Director 1961
Ms. Alisha K. Charlton CFO & Corp. Sec. 1970
Mr. Richard Lee Van Kirk Jr. CEO, President, COO & Director 1961
Ms. Alisha K. Charlton CFO & Corporate Secretary 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…